Skip to main content
. 2022 Jul 31;2022:4450196. doi: 10.1155/2022/4450196

Figure 4.

Figure 4

BMSC activity evaluation. (a–c) Anti-Ki67 expression in control, PLGA, and Chi-MSN groups at 7th day. (d–f) Anti-Ki67 expression in control, PLGA, and Chi-MSN groups at 14th day.